Published in Small on December 01, 2008
Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol (2010) 2.85
Deposition and biokinetics of inhaled nanoparticles. Part Fibre Toxicol (2010) 2.27
Titanium dioxide nanoparticles in food and personal care products. Environ Sci Technol (2012) 1.98
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part Fibre Toxicol (2010) 1.89
The new toxicology of sophisticated materials: nanotoxicology and beyond. Toxicol Sci (2010) 1.71
Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur J Pharm Biopharm (2010) 1.67
Size-dependent in vivo toxicity of PEG-coated gold nanoparticles. Int J Nanomedicine (2011) 1.59
Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev (2012) 1.55
Mechanism of hard-nanomaterial clearance by the liver. Nat Mater (2016) 1.44
Luminescent gold nanoparticles with efficient renal clearance. Angew Chem Int Ed Engl (2011) 1.41
Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int J Nanomedicine (2010) 1.38
Gold nanoparticles: opportunities and challenges in nanomedicine. Expert Opin Drug Deliv (2010) 1.32
Conscripts of the infinite armada: systemic cancer therapy using nanomaterials. Nat Rev Clin Oncol (2010) 1.30
Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm (2010) 1.29
Biodistribution of gold nanoparticles in mouse lung following intratracheal instillation. Chem Cent J (2009) 1.28
Clearance Pathways and Tumor Targeting of Imaging Nanoparticles. ACS Nano (2015) 1.25
Deep penetration of a PDT drug into tumors by noncovalent drug-gold nanoparticle conjugates. J Am Chem Soc (2011) 1.24
Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicology (2011) 1.19
Neurological impacts from inhalation of pollutants and the nose-brain connection. Neurotoxicology (2011) 1.19
Nanoparticles in the lung. Nat Biotechnol (2010) 1.14
The adsorption of biomolecules to multi-walled carbon nanotubes is influenced by both pulmonary surfactant lipids and surface chemistry. J Nanobiotechnology (2010) 1.08
In vivo integrity of polymer-coated gold nanoparticles. Nat Nanotechnol (2015) 1.08
Alveolar epithelial cell injury due to zinc oxide nanoparticle exposure. Am J Respir Crit Care Med (2010) 1.04
Impact of agglomeration state of nano- and submicron sized gold particles on pulmonary inflammation. Part Fibre Toxicol (2010) 1.03
Air-blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle size. ACS Nano (2013) 1.03
Manufactured and airborne nanoparticle cardiopulmonary interactions: a review of mechanisms and the possible contribution of mast cells. Inhal Toxicol (2012) 1.02
An in vitro liver model--assessing oxidative stress and genotoxicity following exposure of hepatocytes to a panel of engineered nanomaterials. Part Fibre Toxicol (2012) 1.01
Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening. Nanotechnology (2013) 0.97
Diesel exhaust particles modulate the tight junction protein occludin in lung cells in vitro. Part Fibre Toxicol (2009) 0.96
Subchronic inhalation toxicity of gold nanoparticles. Part Fibre Toxicol (2011) 0.95
Design rules for nanomedical engineering: from physical virology to the applications of virus-based materials in medicine. J Biol Phys (2013) 0.94
Pulsed ultrasound enhances nanoparticle penetration into breast cancer spheroids. Mol Pharm (2010) 0.94
Small molecule-gold nanorod conjugates selectively target and induce macrophage cytotoxicity towards breast cancer cells. Small (2012) 0.92
An in vitro assessment of panel of engineered nanomaterials using a human renal cell line: cytotoxicity, pro-inflammatory response, oxidative stress and genotoxicity. BMC Nephrol (2013) 0.91
Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging. Int J Nanomedicine (2010) 0.90
Enhancement of cell recognition in vitro by dual-ligand cancer targeting gold nanoparticles. Biomaterials (2011) 0.87
A mixture of anatase and rutile TiO₂ nanoparticles induces histamine secretion in mast cells. Part Fibre Toxicol (2012) 0.87
Toxicological effect of engineered nanomaterials on the liver. Br J Pharmacol (2014) 0.87
Liver uptake of gold nanoparticles after intraperitoneal administration in vivo: a fluorescence study. Lipids Health Dis (2011) 0.85
A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles. Int J Nanomedicine (2013) 0.85
Effects of gestational age and surface modification on materno-fetal transfer of nanoparticles in murine pregnancy. Sci Rep (2012) 0.85
Novel lanthanide-labeled metal oxide nanoparticles improve the measurement of in vivo clearance and translocation. Part Fibre Toxicol (2013) 0.84
Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches. Int J Nanomedicine (2015) 0.84
Hepatic toxicology following single and multiple exposure of engineered nanomaterials utilising a novel primary human 3D liver microtissue model. Part Fibre Toxicol (2014) 0.83
In vitro and in vivo interactions of selected nanoparticles with rodent serum proteins and their consequences in biokinetics. Beilstein J Nanotechnol (2014) 0.83
Effect of gold nanoparticles on glutathione and malondialdehyde levels in liver, lung and heart of rats. Saudi J Biol Sci (2012) 0.83
CuS Nanodots with Ultrahigh Efficient Renal Clearance for Positron Emission Tomography Imaging and Image-Guided Photothermal Therapy. ACS Nano (2015) 0.83
Intratracheally instilled titanium dioxide nanoparticles translocate to heart and liver and activate complement cascade in the heart of C57BL/6 mice. Nanotoxicology (2015) 0.83
Mechanisms of Silver Nanoparticle Release, Transformation and Toxicity: A Critical Review of Current Knowledge and Recommendations for Future Studies and Applications. Materials (Basel) (2013) 0.82
Synthesis and characterization of surface-enhanced Raman-scattered gold nanoparticles. Int J Nanomedicine (2013) 0.81
Demonstration of the clathrin- and caveolin-mediated endocytosis at the maternal-fetal barrier in mouse placenta after intravenous administration of gold nanoparticles. J Vet Med Sci (2013) 0.81
Biodistribution and in vivo toxicity of aptamer-loaded gold nanostars. Nanomedicine (2014) 0.81
Peptide-Targeted Gold Nanoparticles for Photodynamic Therapy of Brain Cancer. Part Part Syst Charact (2015) 0.80
Nanotechnology in respiratory medicine. Respir Res (2015) 0.80
Changes in cardiopulmonary function induced by nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2012) 0.80
Structure-activity relationships for biodistribution, pharmacokinetics, and excretion of atomically precise nanoclusters in a murine model. Nanoscale (2013) 0.79
Virus-based nanomaterials as positron emission tomography and magnetic resonance contrast agents: from technology development to translational medicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2015) 0.79
Allergen particle binding by human primary bronchial epithelial cells is modulated by surfactant protein D. Respir Res (2010) 0.79
Influence of gold, silver and gold-silver alloy nanoparticles on germ cell function and embryo development. Beilstein J Nanotechnol (2015) 0.79
Size dependent translocation and fetal accumulation of gold nanoparticles from maternal blood in the rat. Part Fibre Toxicol (2014) 0.78
Virus-Based Nanoparticles as Versatile Nanomachines. Annu Rev Virol (2015) 0.78
Translocation of gold nanoparticles across the lung epithelial tissue barrier: Combining in vitro and in silico methods to substitute in vivo experiments. Part Fibre Toxicol (2015) 0.78
Intracellular signal modulation by nanomaterials. Adv Exp Med Biol (2014) 0.78
Comparative hazard identification by a single dose lung exposure of zinc oxide and silver nanomaterials in mice. PLoS One (2015) 0.77
Rapamycin ameliorates chitosan nanoparticle-induced developmental defects of preimplantation embryos in mice. Oncotarget (2016) 0.77
Design of virus-based nanomaterials for medicine, biotechnology, and energy. Chem Soc Rev (2016) 0.77
Bidirectional Transfer Study of Polystyrene Nanoparticles across the Placental Barrier in an ex Vivo Human Placental Perfusion Model. Environ Health Perspect (2015) 0.77
Cytotoxicity of gold nanoclusters in human liver cancer cells. Int J Nanomedicine (2014) 0.77
Influence of reducing agents on biosafety and biocompatibility of gold nanoparticles. Appl Biochem Biotechnol (2014) 0.77
Uptake of gold nanoparticles in several rat organs after intraperitoneal administration in vivo: a fluorescence study. Biomed Res Int (2013) 0.77
Nuclear Membrane-Targeted Gold Nanoparticles Inhibit Cancer Cell Migration and Invasion. ACS Nano (2017) 0.76
Combustion By-Products and their Health Effects--combustion engineering and global health in the 21st century: issues and challenges. Int J Toxicol (2014) 0.75
Inhaled Cadmium Oxide Nanoparticles: Their in Vivo Fate and Effect on Target Organs. Int J Mol Sci (2016) 0.75
Ultrathin Ceramic Membranes as Scaffolds for Functional Cell Coculture Models on a Biomimetic Scale. Biores Open Access (2015) 0.75
Assessment of morphological and functional changes in organs of rats after intramuscular introduction of iron nanoparticles and their agglomerates. Biomed Res Int (2015) 0.75
Serum protein adsorption and excretion pathways of metal nanoparticles. Nanomedicine (Lond) (2015) 0.75
Biodistribution, Clearance, and Toxicology of Polymeric Micelles Loaded with 0.9 or 5 nm Gold Nanoparticles. J Biomed Nanotechnol (2015) 0.75
Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution. Mol Pharm (2016) 0.75
Size-dependent cytotoxicity of gold nanoparticles. Small (2007) 4.10
Instillation of six different ultrafine carbon particles indicates a surface area threshold dose for acute lung inflammation in mice. Environ Health Perspect (2006) 2.51
Deposition and biokinetics of inhaled nanoparticles. Part Fibre Toxicol (2010) 2.27
Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small (2009) 2.20
Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particles. Free Radic Biol Med (2005) 2.12
Activation of the WNT/β-catenin pathway attenuates experimental emphysema. Am J Respir Crit Care Med (2010) 1.94
Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. Am J Respir Crit Care Med (2007) 1.83
Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol (2009) 1.78
Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials (2010) 1.77
Effects of particulate air pollution on blood pressure and heart rate in subjects with cardiovascular disease: a multicenter approach. Environ Health Perspect (2004) 1.70
Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ Health Perspect (2007) 1.65
Lesion dose in differentiated thyroid carcinoma metastases after rhTSH or thyroid hormone withdrawal: 124I PET/CT dosimetric comparisons. Eur J Nucl Med Mol Imaging (2010) 1.61
Health effects of particles in ambient air. Int J Hyg Environ Health (2004) 1.55
Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung. Eur J Pharm Biopharm (2010) 1.49
Segmentation of PET volumes by iterative image thresholding. J Nucl Med (2007) 1.43
Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology (2010) 1.38
Expert elicitation on ultrafine particles: likelihood of health effects and causal pathways. Part Fibre Toxicol (2009) 1.35
Deducing in vivo toxicity of combustion-derived nanoparticles from a cell-free oxidative potency assay and metabolic activation of organic compounds. Environ Health Perspect (2008) 1.32
Low-voltage organic transistors with an amorphous molecular gate dielectric. Nature (2004) 1.31
Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm (2010) 1.29
68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors. J Nucl Med (2011) 1.27
Cellular uptake and toxicity of Au55 clusters. Small (2005) 1.23
Ultrafine particles exert prothrombotic but not inflammatory effects on the hepatic microcirculation in healthy mice in vivo. Circulation (2004) 1.22
Role of oxidative stress in ultrafine particle-induced exacerbation of allergic lung inflammation. Am J Respir Crit Care Med (2009) 1.22
Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicology (2011) 1.19
Nanoparticles in the lung. Nat Biotechnol (2010) 1.14
Concentration response functions for ultrafine particles and all-cause mortality and hospital admissions: results of a European expert panel elicitation. Environ Sci Technol (2010) 1.12
Effects of ultrafine carbon particle inhalation on allergic inflammation of the lung. J Allergy Clin Immunol (2006) 1.10
Differences in the biokinetics of inhaled nano- versus micrometer-sized particles. Acc Chem Res (2012) 1.10
Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems. Eur J Nucl Med Mol Imaging (2007) 1.07
Noninvasive imaging of transgene expression by use of positron emission tomography in a pig model of myocardial gene transfer. Circulation (2003) 1.05
Air-blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle size. ACS Nano (2013) 1.03
No significant translocation of inhaled 35-nm carbon particles to the circulation in humans. Inhal Toxicol (2006) 1.03
Cardiovascular responses in unrestrained WKY rats to inhaled ultrafine carbon particles. Inhal Toxicol (2005) 1.01
Nanoparticle delivery in infant lungs. Proc Natl Acad Sci U S A (2012) 0.98
Postnatal lung function in the developing rat. J Appl Physiol (1985) (2008) 0.97
Measurement techniques for respiratory tract deposition of airborne nanoparticles: a critical review. J Aerosol Med Pulm Drug Deliv (2013) 0.96
Metabolism of azo dyes by Lactobacillus casei TISTR 1500 and effects of various factors on decolorization. Water Res (2007) 0.95
The effect of primary particle size on biodistribution of inhaled gold nano-agglomerates. Biomaterials (2013) 0.95
Model for the deposition of aerosol particles in the respiratory tract of the rat. I. Nonhygroscopic particle deposition. J Aerosol Med Pulm Drug Deliv (2008) 0.95
Relationship between different size classes of particulate matter and meteorology in three European cities. J Environ Monit (2005) 0.93
Biodistribution of inhaled gold nanoparticles in mice and the influence of surfactant protein D. J Aerosol Med Pulm Drug Deliv (2012) 0.91
Application of an informatics-based decision-making framework and process to the assessment of radiation safety in nanotechnology. Health Phys (2015) 0.91
68Ga-DOTATOC PET/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax. Eur J Nucl Med Mol Imaging (2011) 0.90
Inflammatory response to TiO2 and carbonaceous particles scales best with BET surface area. Environ Health Perspect (2007) 0.90
Left-to-right asymmetry of aerosol deposition after shallow bolus inhalation depends on lung ventilation. J Aerosol Med Pulm Drug Deliv (2009) 0.89
Serum protein identification and quantification of the corona of 5, 15 and 80 nm gold nanoparticles. Nanotechnology (2013) 0.89
The influence of pulmonary surfactant on nanoparticulate drug delivery systems. Eur J Pharm Biopharm (2010) 0.89
Gold-cluster degradation by the transition of B-DNA into A-DNA and the formation of nanowires. Angew Chem Int Ed Engl (2003) 0.88
A cell factory of Bacillus subtilis engineered for the simple bioconversion of myo-inositol to scyllo-inositol, a potential therapeutic agent for Alzheimer's disease. Microb Cell Fact (2011) 0.88
Ultrafine particles cause cytoskeletal dysfunctions in macrophages: role of intracellular calcium. Part Fibre Toxicol (2005) 0.88
Pulmonary surfactant is indispensable in order to simulate the in vivo situation. Part Fibre Toxicol (2013) 0.88
Purification and characterization of two alkaline, thermotolerant alpha-amylases from Bacillus halodurans 38C-2-1 and expression of the cloned gene in Escherichia coli. Biosci Biotechnol Biochem (2007) 0.87
Constitutive synthesis, purification, and characterization of catechol 1,2-dioxygenase from the aniline-assimilating bacterium Rhodococcus sp. AN-22. J Biosci Bioeng (2004) 0.87
Purification and characterization of two novel halotolerant extracellular proteases from Bacillus subtilis strain FP-133. Biosci Biotechnol Biochem (2006) 0.87
Cloning and functional analysis of aniline dioxygenase gene cluster, from Frateuria species ANA-18, that metabolizes aniline via an ortho-cleavage pathway of catechol. Biosci Biotechnol Biochem (2003) 0.87
Exposure to ultrafine carbon particles at levels below detectable pulmonary inflammation affects cardiovascular performance in spontaneously hypertensive rats. Part Fibre Toxicol (2008) 0.86
Feasibility of central cannabinoid CB1 receptor imaging with [124I]AM281 PET demonstrated in a schizophrenic patient. Psychiatry Res (2006) 0.85
Effects of silver nanoparticles on the liver and hepatocytes in vitro. Toxicol Sci (2012) 0.85
A novel coupled enzyme assay reveals an enzyme responsible for the deamination of a chemically unstable intermediate in the metabolic pathway of 4-amino-3-hydroxybenzoic acid in Bordetella sp. strain 10d. Eur J Biochem (2004) 0.85
The influence of hydrogen peroxide and histamine on lung permeability and translocation of iridium nanoparticles in the isolated perfused rat lung. Part Fibre Toxicol (2005) 0.85
Binding of polystyrene and carbon black nanoparticles to blood serum proteins. Inhal Toxicol (2011) 0.84
Soluble iron modulates iron oxide particle-induced inflammatory responses via prostaglandin E(2 )synthesis: In vitro and in vivo studies. Part Fibre Toxicol (2009) 0.84
Differential hERG ion channel activity of ultrasmall gold nanoparticles. Proc Natl Acad Sci U S A (2013) 0.84
Screening and characterization of bacteria that can utilize ammonium and nitrate ions simultaneously under controlled cultural conditions. J Biosci Bioeng (2007) 0.83
Cellular uptake and localization of inhaled gold nanoparticles in lungs of mice with chronic obstructive pulmonary disease. Part Fibre Toxicol (2013) 0.83
Efficient internalization and intracellular translocation of inhaled gold nanoparticles in rat alveolar macrophages. Nanomedicine (Lond) (2012) 0.83
Purification, characterization, and gene cloning of cis,cis-muconate cycloisomerase from benzamide-assimilating Arthrobacter sp. BA-5-17. FEMS Microbiol Lett (2004) 0.83
Source apportionment of ambient fine particle size distribution using positive matrix factorization in Erfurt, Germany. Sci Total Environ (2008) 0.83
Effects of ultrafine particles-induced oxidative stress on Clara cells in allergic lung inflammation. Part Fibre Toxicol (2010) 0.83
Pathway focused protein profiling indicates differential function for IL-1B, -18 and VEGF during initiation and resolution of lung inflammation evoked by carbon nanoparticle exposure in mice. Part Fibre Toxicol (2009) 0.83
Three inositol dehydrogenases involved in utilization and interconversion of inositol stereoisomers in a thermophile, Geobacillus kaustophilus HTA426. Microbiology (2012) 0.82